BioHealth News Archive
15 companies graduate from UMBC’s bwtech, ready to grow on their own – Baltimore Business Journal
More than 110 companies have graduated since bwtech@UMBC began offering incubation services in 1989. {iframe}https://www.bizjournals.com/baltimore/news/2018/01/11/15-companies-graduate-from-umbcs-bwtech-ready-to.html{/iframe}
Read More
Cell Therapy Manufacturing: All Signs Point to Commercialization – GEN
Cell therapy is the delivery of living cells to treat, or potentially cure, a person’s disease. The transplantation of hematopoietic stem cells from a…
Read More
Apply to Trajectory Next- University of Maryland Graduate School
Trajectory Next will provide formalized support and guidance to companies to help them execute a pilot, establish traction, and improve their ability to attract…
Read MoreTAI Diagnostics Raises $10M, Inks Deal With United Therapeutics – Xconomy
TAI Diagnostics said earlier this week that it had closed a $10 million round of funding and forged a new partnership with United Therapeutics…
Read More
GSK CEO Emma Walmsley on diversity in pharma – INSIDER
GlaxoSmithKline CEO Emma Walmsley made history in 2017, when she became the first woman to head up a major pharmaceutical company. {iframe}http://www.thisisinsider.com/gsk-ceo-emma-walmsley-on-diversity-in-pharma-2018-1{/iframe}
Read More
The Sad Story of How a DC Tech Incubator Fell Apart – Washingtonian
Once heralded as a centerpiece of DC’s tech scene, start-up incubator 1776 proved less revolutionary than its name. {iframe}https://www.washingtonian.com/2018/01/11/sad-story-how-dc-tech-incubator-1776-fell-apart/{/iframe}
Read More
EU Approves AstraZeneca’s Respiratory Biologic | BioPharm International
AstraZeneca and MedImmune, its biologics research and development arm, announced that the European Commission (EC) has approved the companies’ respiratory biologic, benralizumab, as an…
Read More
The 10 Most Innovative Life Sciences Deals of 2017 – LAKE WHILLANS
In recent years, Lake Whillans has published extensively on the multifaceted interplay between the legal market and the life sciences industry, specifically identifying the…
Read More
Jackson Lab Wins $3.2M NIH Grant to Develop Epigenome Modification Tech – GenomeWeb
The Jackson Laboratory has been awarded a $3.2 million grant from the National Institutes of Health to develop an epigenome modification technology for studying…
Read More
PepVax Announces Completion of Efficacy Study with Key Pre-Clinical Data to Validate PVX-009,
PepVax, Inc., an early-stage biotechnology company, announced today that it has successfully completed the efficacy study for its lead candidate, PVX-009. The Company is…
Read More
Novavax veteran lines up as next president of Icon’s ClinicalRM | FierceBiotech
Icon has hired a retired colonel who is moving into the biotech sphere as new president of its subsidiary ClinicalRM. James Cummings, M.D., will lead…
Read More
Precision For Medicine Expands Services In Europe, Announces Next Generation Biomarker Data Management And Translational Informatics Platform
Precision for Medicine, part of Precision Medicine Group, today announced it is expanding its biomarker data management and translational informatics services into Europe. The…
Read More
REGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the Development and Commercialization of Treatments for Spinal Muscular Atrophy Nasdaq:AVXS
REGENXBIO Inc. (Nasdaq:RGNX) and AveXis, Inc. (Nasdaq:AVXS) today announced that they have entered into an amendment which expands upon the exclusive, worldwide license agreement…
Read More
Qiagen and DiaSorin partner on tuberculosis testing
Qiagen has announced a new partnership with DiaSorin that will allow the companies to offer new automated tuberculosis detection capabilities for their customers. {iframe}https://www.zenopa.com/news/801843584/qiagen-and-diasorin-partner-on-tuberculosis-testing{/iframe}
Read More![Pfizer Halts Drug Research For Alzheimer’s and Parkinson’s Because It’s Too Expensive [Updated]](https://wpdev.biohealthinnovation.org/wp-content/uploads/2014/04/pfizer-logo.png){kind=logo}
Pfizer Halts Drug Research For Alzheimer’s and Parkinson’s Because It’s Too Expensive [Updated]
Pfizer, one of the world’s largest drug companies, announced over the weekend that it would stop work on new drugs to fight Alzheimer’s disease…
Read More